Gene Therapy for Cystic Fibrosis

T is a single gene defect on Chr 7; It is a recessive condition, with heterozygotes being phenotypically normal (suggesting gene dosage effects are not critical); The main pathology is in the lung, which is accessible for treatment; It is a progressive disease with a virtually normal phenotype at birth, offering a therapeutic window